Skip to content
OpenCapital
Get started

Twist Bioscience Corporation TWST Share-Based Payment Award Options Outstanding - Number

Share-Based Payment Award Options Outstanding - Number at other companies

10x Genomics, Inc. logo
10x Genomics, Inc.TXG
3.4M-18.9%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%
Enterprise value$5.44B+30.4%
P/S13.3×+0.7×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's share-based payment award options outstanding - number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's share-based payment award options outstanding - number?
Twist Bioscience Corporation (TWST) reported share-based payment award options outstanding - number of 1.2M in Q1 2026.
How has Twist Bioscience Corporation's share-based payment award options outstanding - number changed year-over-year?
Twist Bioscience Corporation's share-based payment award options outstanding - number decreased by 25.9% year-over-year, from 1.6M to 1.2M.
What is the long-term trend for Twist Bioscience Corporation's share-based payment award options outstanding - number?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's share-based payment award options outstanding - number has grown at a -18.4% compound annual growth rate (CAGR), from 2.9M to 1.3M.
What does share-based payment award options outstanding - number mean?
This is the total count of stock options granted to employees and directors that remain unexercised at the reporting date. It reflects the total volume of potential equity claims currently held by the workforce. This metric is a key component in calculating fully diluted share counts.